US Senator Elizabeth Warren has asked the Federal Trade Commission (FTC) to look into a $16.5 billion deal that would give ...

Sanofi said in October last year that it was planning to spin off its consumer health business into a separate company before ...

GSK said it expects to take a charge of £1.8 billion ($2.3 billion) in its third-quarter results in relation to the ...

The consultation on raising the threshold suggests that this change will “ensure that the BIT continues to target those ...

Pfizer's ex-chair and chief executive Ian Read and Frank D'Amelio – previously the drugmaker's finance chief – have issued a ...

MERGE announces new Chair. MERGE, a Chicago-based integrated technology and marketing services provider, has a new board ...

Our round-up of recent biotech financings features a strong first round for City Therapeutics, a new RNAi venture led by ...

The approach can be transformative. When patients feel heard and understood, they’re more likely to engage actively and ...

Artificial intelligence (AI) is an increasingly valuable tool in our perpetual quest for the miracles that science regularly ...

For the pharma industry, the IRA has made headlines due to it allowing price negotiations on top-selling treatments. However, ...

Novartis' Piqray/Vijoice (alpelisib) is the only PIK3CA inhibitor to have reached the market for breast cancer, having been ...

The landscape of medical technology start-ups is undoubtedly poised for significant evolution due to the FDA’s final rule.